Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 239

1.

Seroprevalence of hepatitis viruses and risk factors in blood donors of Veracruz, Mexico.

Lopez-Balderas N, Bravo E, Camara M, Hernandez-Romano P.

J Infect Dev Ctries. 2015 Mar 15;9(3):274-82. doi: 10.3855/jidc.4812.

2.

[Natural clearance of hepatitis C virus in 96 patients with infection acquired by blood transfusion from a single donor in Guizhou].

Liu S, Cheng M, Mu M, Yang Q.

Zhonghua Gan Zang Bing Za Zhi. 2014 Apr;22(4):251-4. doi: 10.3760/cma.j.issn.1007-3418.2014.04.003. Chinese.

PMID:
25173221
3.

Seronegative hepatitis C virus infection.

Kaźmierczak J, Pawełczyk A, Cortes KC, Radkowski M.

Arch Immunol Ther Exp (Warsz). 2014 Apr;62(2):145-51. doi: 10.1007/s00005-013-0257-7. Epub 2013 Nov 9. Review.

4.

Multicenter evaluation of the Elecsys® anti-HCV II assay for the diagnosis of hepatitis C virus infection.

Esteban JI, van Helden J, Alborino F, Bürgisser P, Cellerai C, Pantaleo G, Eiras A, Rodriguez MI, Ghisetti V, Gleich M, Imdahl R, Kaiser C, Möller P, Wetlitzky O, Segovia M, Schennach H, Mühlbacher A.

J Med Virol. 2013 Aug;85(8):1362-8. doi: 10.1002/jmv.23536.

PMID:
23765774
5.

Probable hepatitis C virus transmission from a seronegative blood donor via cellular blood products.

Biceroglu SU, Turhan A, Doskaya AD, Yamazhan T, Donmez A, Altuglu I, Aydinok Y, Sertoz RY.

Blood Transfus. 2014 Jan;12 Suppl 1:s69-70. doi: 10.2450/2013.0285-12. Epub 2013 May 6. No abstract available.

6.

Prevalence of HCV among the young male blood donors of Quetta region of Balochistan, Pakistan.

Khan A, Tareen AM, Ikram A, Rahman H, Wadood A, Qasim M, Khan K.

Virol J. 2013 Mar 13;10:83. doi: 10.1186/1743-422X-10-83.

7.

Liver transplant from an ABO-incompatible and hepatitis C antibody-positive but an HCV-RNA negative living donor in a familial amyloid polyneuropathy patient.

Takeichi T, Asonuma K, Yamamoto H, Ohya Y, Okumura K, Lee KJ, Inomata Y.

Exp Clin Transplant. 2013 Apr;11(2):182-5. doi: 10.6002/ect.2012.0158. Epub 2012 Nov 22.

8.

Hepatitis C and renal transplantation.

Morales JM, Aguado JM.

Curr Opin Organ Transplant. 2012 Dec;17(6):609-15. doi: 10.1097/MOT.0b013e32835a2bac. Review.

PMID:
23111646
9.

Liver transplantation from anti-hepatitis C virus-positive donors: our experience.

Álvaro E, Abradelo M, Fuertes A, Manrique A, Colina F, Alegre C, Calvo J, García M, García-Sesma A, Cambra F, Sanabria R, Moreno E, Jimenez C.

Transplant Proc. 2012 Jul-Aug;44(6):1475-8. doi: 10.1016/j.transproceed.2012.05.012.

PMID:
22841188
10.

Detection of specific antibodies to HCV-ARF/CORE+1 protein in patients treated with pegylated interferon plus ribavirin.

Karamitros T, Kakkanas A, Katsoulidou A, Sypsa V, Dalagiorgou G, Mavromara P, Hatzakis A.

J Viral Hepat. 2012 Mar;19(3):182-8. doi: 10.1111/j.1365-2893.2011.01502.x. Epub 2011 Oct 4.

PMID:
22329372
11.

Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study.

Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS Jr, Stravitz RT, Duman JD, Forman LM, Terrault NA; Consortium to Study Health Outcomes in HCV Liver Transplant Recipients (CRUSH-C).

Liver Transpl. 2012 May;18(5):532-8. doi: 10.1002/lt.23396.

12.

Should we be using kidneys from hepatitis C virus-infected donors?

Domínguez-Gil B, Andrés A, Campistol JM, Morales JM.

Curr Opin Nephrol Hypertens. 2011 Nov;20(6):599-604. doi: 10.1097/MNH.0b013e32834bba37. Review.

PMID:
21946162
13.

Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.

Venturi C, Bueno J, Castells L, Quintero J, Casas I, Allende H, Martinez-Ibañez V, Charco R.

Liver Transpl. 2011 Dec;17(12):1474-80. doi: 10.1002/lt.22439.

14.

Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.

Batchoun RG, Al-Najdawi MA, Al-Taamary S.

Saudi J Kidney Dis Transpl. 2011 Jul;22(4):682-8.

15.

Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study.

Ballarin R, Cucchetti A, Spaggiari M, Montalti R, Di Benedetto F, Nadalin S, Troisi RI, Valmasoni M, Longo C, De Ruvo N, Cautero N, Cillo U, Pinna AD, Burra P, Gerunda GE.

Transplantation. 2011 Jun 15;91(11):1265-72. doi: 10.1097/TP.0b013e318219eb8f.

PMID:
21478815
16.

Prevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV.

Khan NU, Ali I, Ahmad NU, Iqbal A, Rehman LU, Munir I, Rehman MU, Khan S, Ali S, Siddique L, Swati ZA.

Virol J. 2011 Apr 1;8:154. doi: 10.1186/1743-422X-8-154.

17.

Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale.

Tanaka J, Koyama T, Mizui M, Uchida S, Katayama K, Matsuo J, Akita T, Nakashima A, Miyakawa Y, Yoshizawa H.

Intervirology. 2011;54(4):185-95. doi: 10.1159/000324525. Epub 2011 Mar 30.

PMID:
21454956
18.

Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden.

Ydreborg M, Söderström A, Håkanson A, Alsiö A, Arnholm B, Malmström P, Hellstrand K, Westin J, Lagging M.

Scand J Infect Dis. 2011 Jul;43(6-7):522-7. doi: 10.3109/00365548.2011.562526. Epub 2011 Mar 7.

PMID:
21375426
19.

Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis C-positive recipients.

Morales JM, Campistol JM, Domínguez-Gil B, Andrés A, Esforzado N, Oppenheimer F, Castellano G, Fuertes A, Bruguera M, Praga M.

Am J Transplant. 2010 Nov;10(11):2453-62. doi: 10.1111/j.1600-6143.2010.03280.x.

20.

Prevalence and factors associated with hepatitis C virus infection among Myanmar blood donors.

Myo-Khin, San-San-Oo, Oo KM, Shimono K, Koide N, Okada S.

Acta Med Okayama. 2010 Oct;64(5):317-21.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk